Publications by authors named "Ron Pedersen"

Claim this Profile
E
Erosions on T1-Weighted Magnetic Resonance Imaging Versus Radiography of Sacroiliac Joints in Recent-Onset Axial Spondyloarthritis: 2-Year Data (EMBARK Trial and DESIR Cohort).
Walter P Maksymowych, Pascal Claudepierre, Manouk de Hooge, Robert G Lambert, Robert Landewé, Ron Pedersen

J Rheumatol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiographic and clinical effects of 10 mg and 25 mg twice-weekly etanercept over 52 weeks in Japanese patients with active rheumatoid arthritis.
Tsutomu Takeuchi, Nobuyuki Miyasaka, Ron D Pedersen, Noriko Sugiyama, Tomohiro Hirose

Mod Rheumatol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structural changes in the sacroiliac joint on MRI and relationship to ASDAS inactive disease in axial spondyloarthritis: a 2-year study comparing treatment with etanercept in EMBARK to a contemporary control cohort in DESIR.
Walter P Maksymowych, Pascal Claudepierre, Manouk de Hooge, Robert G Lambert, Robert Landewé, Ron Pedersen

Arthritis Res Ther· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiographic and clinical outcomes following etanercept monotherapy in Japanese methotrexate-naïve patients with active rheumatoid arthritis.
Tsutomu Takeuchi, Nobuyuki Miyasaka, Ron Pedersen, Noriko Sugiyama, Tomohiro Hirose

Mod Rheumatol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Analysis of Real-World Data on the Safety of Etanercept in Older Patients with Rheumatoid Arthritis.
Christopher J Edwards, Jack F Bukowski, Sara M Burns, Heather E Jones, Ron Pedersen

Drugs Aging· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship between disease activity status or clinical response and patient-reported outcomes in patients with non-radiographic axial spondyloarthritis: 104-week results from the randomized controlled EMBARK study.
Maxime Dougados, Désirée van der Heijde, Wen-Chan Tsai, Diego Saaibi, Lisa Marshall, Ron Pedersen

Health Qual Life Outcomes· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of Tofacitinib for Treatment of Ulcerative Colitis, Based on 4.4 Years of Data From Global Clinical Trials.
William J Sandborn, Julián Panés, Geert R D'Haens, Bruce E Sands, Chinyu Su, Ron Pedersen

Clin Gastroenterol Hepatol· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A single-arm, open-label study to assess the immunogenicity, safety, and efficacy of etanercept manufactured using the serum-free, high-capacity manufacturing process administered to patients with rheumatoid arthritis.
Pavol Polák, Porin Peric, Ingrid Louw, Stefanie M Gaylord, Theresa Williams, Ron Pedersen

Eur J Rheumatol· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Prevalence of Non-radiographic Axial Spondyloarthritis Among Patients with Inflammatory Back Pain from Northwest and South Africa: Data from a Noninterventional, Cross-Sectional Study.
Khalid Shirazy, Najia Hajjaj-Hassouni, Constance Hammond, Heather Jones, Aicha Ladjouze Rezig, Ron Pedersen

Rheumatol Ther· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maintenance of low disease activity and remission with etanercept-disease-modifying antirheumatic drug (DMARD) combination therapy compared with treatment with DMARDs alone in Latin American patients with active rheumatoid arthritis: Subset analysis of a randomized trial.
Cristiano A F Zerbini, Carlos Abud-Mendoza, Paul Mendez-Patarroyo, Mauricio De Angelo Andrade, Ron Pedersen

Medicine (Baltimore)· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of Antidrug Antibodies in Rheumatoid Arthritis Patients From Argentina Treated With Adalimumab, Etanercept, or Infliximab in a Real-World Setting.
Pablo J Maid, Ricardo Xavier, Rosa M Real, Ron Pedersen, Qi Shen

J Clin Rheumatol· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maintenance of Remission with Etanercept-DMARD Combination Therapy Compared with DMARDs Alone in African and Middle Eastern Patients with Active Rheumatoid Arthritis.
Hassan Bassiouni, Catherine Elizabeth Spargo, Bonnie Vlahos, Heather E Jones, Ron Pedersen

Rheumatol Ther· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the change in structural radiographic sacroiliac joint damage after 2 years of etanercept therapy (EMBARK trial) in comparison to a contemporary control cohort (DESIR cohort) in recent onset axial spondyloarthritis.
Maxime Dougados, Walter P Maksymowych, Robert B M Landewé, Anna Moltó, Pascal Claudepierre, Ron Pedersen

Ann Rheum Dis· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modification of structural lesions on MRI of the sacroiliac joints by etanercept in the EMBARK trial: a 12-week randomised placebo-controlled trial in patients with non-radiographic axial spondyloarthritis.
Walter P Maksymowych, Stephanie Wichuk, Maxime Dougados, Heather E Jones, Ron Pedersen

Ann Rheum Dis· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tuberculosis and viral hepatitis infection in Eastern Europe, Asia, and Latin America: impact of tumor necrosis factor-α inhibitors in clinical practice.
Yi-Hsing Chen, Hellen Mds de Carvalho, Umut Kalyoncu, Lyndon John Q Llamado, Gaston Solano, Ron Pedersen

Biologics· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Long-Term Etanercept Treatment on Clinical Outcomes and Objective Signs of Inflammation in Early Nonradiographic Axial Spondyloarthritis: 104-Week Results From a Randomized, Placebo-Controlled Study.
Maxime Dougados, Désirée van der Heijde, Joachim Sieper, Jürgen Braun, Gustavo Citera, Ron Pedersen

Arthritis Care Res (Hoboken)· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of anti-drug antibodies on drug concentrations and clinical outcomes in rheumatoid arthritis patients treated with adalimumab, etanercept, or infliximab: Results from a multinational, real-world clinical practice, non-interventional study.
Robert J Moots, Ricardo M Xavier, Chi Chiu Mok, Mahboob U Rahman, Wen-Chan Tsai, Ron Pedersen

PLoS One· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: The impact of anti-drug antibodies on drug concentrations and clinical outcomes in rheumatoid arthritis patients treated with adalimumab, etanercept, or infliximab: Results from a multinational, real-world clinical practice, non-interventional study.
Robert J Moots, Ricardo M Xavier, Chi Chiu Mok, Mahboob U Rahman, Wen-Chan Tsai, Ron Pedersen

PLoS One· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dr. Wiland, et al, reply.
Piotr Wiland, Jean Dudler, Douglas Veale, Hasan Tahir, Ron Pedersen

J Rheumatol· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and MRI responses to etanercept in early non-radiographic axial spondyloarthritis: 48-week results from the EMBARK study.
Walter P Maksymowych, Maxime Dougados, Désirée van der Heijde, Joachim Sieper, Jürgen Braun, Ron Pedersen

Ann Rheum Dis· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Effect of Reduced or Withdrawn Etanercept-methotrexate Therapy on Patient-reported Outcomes in Patients with Early Rheumatoid Arthritis.
Piotr Wiland, Jean Dudler, Douglas Veale, Hasan Tahir, Ron Pedersen

J Rheumatol· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum to: The prevalence and clinical characteristics of nonradiographic axial spondyloarthritis among patients with inflammatory back pain in rheumatology practices: a multinational, multicenter study.
Ruben Burgos-Vargas, James Cheng-Chung Wei, Mahboob U Rahman, Nurullah Akkoc, Syed Atiqul Haq, Ron Pedersen

Arthritis Res Ther· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prevalence and clinical characteristics of nonradiographic axial spondyloarthritis among patients with inflammatory back pain in rheumatology practices: a multinational, multicenter study.
Ruben Burgos-Varga, James Cheng-Chung Wei, Mahboob U Rahman, Nurullah Akkoc, Syed Atiqul Haq, Ron Pedersen

Arthritis Res Ther· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of Health Outcomes with Etanercept Treatment in Patients with Early Nonradiographic Axial Spondyloarthritis.
Maxime Dougados, Wen-Chan Tsai, Diego L Saaibi, Randi Bonin, Jack Bukowski, Ron Pedersen

J Rheumatol· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Symptomatic efficacy of etanercept and its effects on objective signs of inflammation in early nonradiographic axial spondyloarthritis: a multicenter, randomized, double-blind, placebo-controlled trial.
Maxime Dougados, Désirée van der Heijde, Joachim Sieper, Jürgen Braun, Walter P Maksymowych, Ron Pedersen

Arthritis Rheumatol· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis